Kupando GmbH: Clinical Trials

1 trial sponsored by Kupando GmbH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Kupando GmbH: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors
KUP-101A - Cutaneous Melanoma, Mucosal Melanoma
Phase 1RecruitingKupando GmbH212026-07-032026-08-12

Conditions studied

Carcinoma, Basal Cell (1)  ·  Melanoma (1)  ·  Skin Neoplasms (1)

Countries

Germany (1)

NIH funding

2025 (1)